Menu
1 min read · estimated
APPROVED USE
What FDA approved
Maintenance therapy for adults with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer in complete or partial response to first-line platinum-based chemotherapy. The original decision had no biomarker requirement.
LAMPGEN ANALYSIS
Why it matters
Brought PARP inhibitor maintenance into first-line care for platinum responders under the original label.
What research teams should watch
Record platinum response and baseline blood counts and weight for dose selection and monitoring.
PRIMARY RECORDS